Home

Articles from Zenflow

FDA Approves the Zenflow Spring® Implant and Delivery System for First-Line Interventional Therapy of Patients with Benign Prostatic Hyperplasia (BPH)
Long-Term Data Supports Three-Year Durability
By Zenflow · Via GlobeNewswire · December 11, 2025
Zenflow Receives FDA 510(k) Clearance for First-of-Its-Kind Single-Use Cystoscope
Spring® Scope delivers the largest working channel of any flexible single-use cystoscope, enhancing visualization and patient comfort
By Zenflow · Via GlobeNewswire · September 30, 2025
Three-Year Data of Zenflow’s Spring System Demonstrate Durability of Clinical Benefits for Patients Suffering from BPH
Data Presented at the AUA Meeting Reflect Longest-Term Data among FIT Interventions
By Zenflow · Via GlobeNewswire · April 26, 2025